Elizabeth Holmes, the founder and former CEO of medical startup firm Theranos, has been sentenced to 135 months (just over 11.25 years) in prison for her role in defrauding investors and consumers with a faulty blood-testing device that she claimed had massive potential.

A jury found Holmes guilty of three counts of wire fraud and one count of conspiracy to commit wire fraud earlier this year, and U.S. District Court Judge Edward Davila announced the sentence on Friday after a four-hour hearing. Following Holmes' time in jail, she will face three years of supervised release.

Holmes' story hit television screens this year in the Hulu limited series The Dropout. Starring Amanda Seyfried and Naveen Andrews, the show recounted the story of the Stanford University dropout who became the face of fraud in Silicon Valley. The series was highly acclaimed, and Seyfried won an Emmy in September for her portrayal of Holmes. Now, Seyfried's real life subject is going behind bars.

Back in the mid-2010s, Holmes was heavily promoted as a visionary entrepreneur. She was touted as the first self-made female tech billionare, and she promised that Theranos was developing a revolutionary technology that would make blood testing cheaper, easier and less painful. The company raised nearly $1 billion in private investment despite never proving that the technology worked.

In late 2015, Holmes' empire started to crumble, with investigative reporting from The Wall Street Journal casting doubt on the company's claims. Eventually, the Securities and Exchange Commission got involved and federal fraud charges were levied.

Holmes' story has been followed on many other forms of media aside from The Dropout. Bad Blood: Secrets and Lies in a Silicon Valley Startup, a book by the reporter who broke the original story, was transformed into a podcast, and a documentary for HBO titled Inventor: Out for Blood in Silicon Valley was released in 2019.

Carson Burton is a freelance news writer for IGN. You can follow him on Twitter at @carsonsburton.

Elizabeth Holmes, the founder and former CEO of medical startup firm Theranos, has been sentenced to 135 months (just over 11.25 years) in prison for her role in defrauding investors and consumers with a faulty blood-testing device that she claimed had massive potential.

A jury found Holmes guilty of three counts of wire fraud and one count of conspiracy to commit wire fraud earlier this year, and U.S. District Court Judge Edward Davila announced the sentence on Friday after a four-hour hearing. Following Holmes' time in jail, she will face three years of supervised release.

Holmes' story hit television screens this year in the Hulu limited series The Dropout. Starring Amanda Seyfried and Naveen Andrews, the show recounted the story of the Stanford University dropout who became the face of fraud in Silicon Valley. The series was highly acclaimed, and Seyfried won an Emmy in September for her portrayal of Holmes. Now, Seyfried's real life subject is going behind bars.

Back in the mid-2010s, Holmes was heavily promoted as a visionary entrepreneur. She was touted as the first self-made female tech billionare, and she promised that Theranos was developing a revolutionary technology that would make blood testing cheaper, easier and less painful. The company raised nearly $1 billion in private investment despite never proving that the technology worked.

In late 2015, Holmes' empire started to crumble, with investigative reporting from The Wall Street Journal casting doubt on the company's claims. Eventually, the Securities and Exchange Commission got involved and federal fraud charges were levied.

Holmes' story has been followed on many other forms of media aside from The Dropout. Bad Blood: Secrets and Lies in a Silicon Valley Startup, a book by the reporter who broke the original story, was transformed into a podcast, and a documentary for HBO titled Inventor: Out for Blood in Silicon Valley was released in 2019.

Carson Burton is a freelance news writer for IGN. You can follow him on Twitter at @carsonsburton.

Update 11/18 3:45 pm PT: A half hour after the outage, Steam appears to be back online. Happy gaming!

Original Story: Steam appears to be down as users are reporting a sudden outage at the world’s largest PC games launcher and store.

According to IGN’s sister site DownDetector, users are reporting a sudden outage on Steam. Our own attempts to log into Steam have been unsuccessful. It’s unclear what caused the sudden outage.

There’s been no official word from Valve on what caused the outage and when services might resume.

Steam is getting ready to launch its next big sale, the Steam Autumn Sale which will begin on November 22 and last through November 29.

IGN will update this story when Steam services resume, but until then you can keep checking IGN for regular updates.

Matt T.M. Kim is IGN's News Editor. You can reach him @lawoftd.

Update 11/18 3:45 pm PT: A half hour after the outage, Steam appears to be back online. Happy gaming!

Original Story: Steam appears to be down as users are reporting a sudden outage at the world’s largest PC games launcher and store.

According to IGN’s sister site DownDetector, users are reporting a sudden outage on Steam. Our own attempts to log into Steam have been unsuccessful. It’s unclear what caused the sudden outage.

There’s been no official word from Valve on what caused the outage and when services might resume.

Steam is getting ready to launch its next big sale, the Steam Autumn Sale which will begin on November 22 and last through November 29.

IGN will update this story when Steam services resume, but until then you can keep checking IGN for regular updates.

Matt T.M. Kim is IGN's News Editor. You can reach him @lawoftd.

Millie Gibson is Doctor Who's newest companion. Gibson will play Ruby Sunday, joining Ncuti Gatwa in the fifteenth generation of Doctor Who. The announcement was made live on BBC Children in Need on Friday.

Gibson, who is currently 18-years-old, is best known for her role on Coronation Street as Kellie Neelan. She has also appearend in the shows Butterfly and Love, Lies and Records. Now, Gibson will join the Time Lord in the Tardis when the series returns in the end of 2023.

"Whilst still being in total disbelief, I am beyond honoured to be cast as the Doctor’s companion," Gibson told the BBC. "It is a gift of a role, and a dream come true, and I will do everything to try and fill the boots the fellow companions have travelled in before me. And what better way to do that than being by the fabulous Ncuti Gatwa’s side, I just can’t wait to get started."

Gibson is joining a new era of Doctor Who that is striving to break barriers. Gatwa, the 30-year-old Sex Education star, is the first black actor to portray the Doctor as a series lead. He will take over the helm of Time Lord from Jodie Whittaker, the first female protagonist on the show. Throughout her four-year tenure, Mandip Gill played Whittaker's sidekick, Yasmin Khan. Now, Gibson and Gatwa are taking over the reins.

"Millie just is the Companion," Gatwa said. "She is full of talent, strength, she has a cheeky sparkle in her eye and is sharp as a razor. From the moment she walked into the room she captured all of our attention with her effervescence and then solidified that attention with the sheer torque of her talent. This adventure is going to be so wild and so fun, I cannot WAIT to sail the universe with Millie!"

Doctor Who is expected to return next year with Russell T Davies at the helm. Before Gatwa's debut is aired, David Tennant will return as the Doctor in three episodes for Doctor Who's 60th anniversary.

Carson Burton is a freelance news writer for IGN. You can follow him on Twitter at @carsonsburton.

Millie Gibson is Doctor Who's newest companion. Gibson will play Ruby Sunday, joining Ncuti Gatwa in the fifteenth generation of Doctor Who. The announcement was made live on BBC Children in Need on Friday.

Gibson, who is currently 18-years-old, is best known for her role on Coronation Street as Kellie Neelan. She has also appearend in the shows Butterfly and Love, Lies and Records. Now, Gibson will join the Time Lord in the Tardis when the series returns in the end of 2023.

"Whilst still being in total disbelief, I am beyond honoured to be cast as the Doctor’s companion," Gibson told the BBC. "It is a gift of a role, and a dream come true, and I will do everything to try and fill the boots the fellow companions have travelled in before me. And what better way to do that than being by the fabulous Ncuti Gatwa’s side, I just can’t wait to get started."

Gibson is joining a new era of Doctor Who that is striving to break barriers. Gatwa, the 30-year-old Sex Education star, is the first black actor to portray the Doctor as a series lead. He will take over the helm of Time Lord from Jodie Whittaker, the first female protagonist on the show. Throughout her four-year tenure, Mandip Gill played Whittaker's sidekick, Yasmin Khan. Now, Gibson and Gatwa are taking over the reins.

"Millie just is the Companion," Gatwa said. "She is full of talent, strength, she has a cheeky sparkle in her eye and is sharp as a razor. From the moment she walked into the room she captured all of our attention with her effervescence and then solidified that attention with the sheer torque of her talent. This adventure is going to be so wild and so fun, I cannot WAIT to sail the universe with Millie!"

Doctor Who is expected to return next year with Russell T Davies at the helm. Before Gatwa's debut is aired, David Tennant will return as the Doctor in three episodes for Doctor Who's 60th anniversary.

Carson Burton is a freelance news writer for IGN. You can follow him on Twitter at @carsonsburton.

The Justice Department has opened an antitrust investigation into Live Nation Entertainment following a fiasco earlier this week concerning its subsidiary Ticketmaster.

The New York Times reports that the Justice Department is investigating the company to determine whether or not Live Nation Entertainment abused its market power in the live events business. Earlier this week, pre-sale tickets for Taylor Swift's upcoming "Eras" tour when up, and the website crashed due to overwhelming demand.

Due to extraordinarily high demands on ticketing systems and insufficient remaining ticket inventory to meet that demand, tomorrow's public on-sale for Taylor Swift | The Eras Tour has been cancelled.

— Ticketmaster (@Ticketmaster) November 17, 2022

Ticketmaster then announced on Thursday that it was canceling the public sale of Swift's tour due to "extraordinarily high demands on ticketing systems and insufficient remaining ticket inventory to meet that demand."

Live Nation Entertainment has previously been under antitrust controversy as the company is currently under a consent decree as part of a settlement with the Justice Department following its merger with Ticketmaster in 2010.

However, this is not the only legal probe against Live Nation and Ticketmaster, as the Attorney Generals for North Carolina and Tennessee announced that they were also investigating Ticketmaster due to the Taylor Swift pre-sale ticket fiasco.

Taylor is the Associate Tech Editor at IGN. You can follow her on Twitter @TayNixster.

The Justice Department has opened an antitrust investigation into Live Nation Entertainment following a fiasco earlier this week concerning its subsidiary Ticketmaster.

The New York Times reports that the Justice Department is investigating the company to determine whether or not Live Nation Entertainment abused its market power in the live events business. Earlier this week, pre-sale tickets for Taylor Swift's upcoming "Eras" tour when up, and the website crashed due to overwhelming demand.

Due to extraordinarily high demands on ticketing systems and insufficient remaining ticket inventory to meet that demand, tomorrow's public on-sale for Taylor Swift | The Eras Tour has been cancelled.

— Ticketmaster (@Ticketmaster) November 17, 2022

Ticketmaster then announced on Thursday that it was canceling the public sale of Swift's tour due to "extraordinarily high demands on ticketing systems and insufficient remaining ticket inventory to meet that demand."

Live Nation Entertainment has previously been under antitrust controversy as the company is currently under a consent decree as part of a settlement with the Justice Department following its merger with Ticketmaster in 2010.

However, this is not the only legal probe against Live Nation and Ticketmaster, as the Attorney Generals for North Carolina and Tennessee announced that they were also investigating Ticketmaster due to the Taylor Swift pre-sale ticket fiasco.

Taylor is the Associate Tech Editor at IGN. You can follow her on Twitter @TayNixster.

It's seemingly official: Pokérus is gone. Pokémon Scarlet and Violet just released on Thursday, but players are already discovering the rare, fictional disease is not present in the new games.

Pokérus was first introduced in Gen 2 Pokémon games. The status is essentially a virus; it infects any Pokémon adjacent to an infected Pokémon in your party, even though they're both still in Poké Balls.

The disappearance of Pokérus was discovered by Twitter user and dataminer @mattyoukhana_, who found that the game's code showed no indication of Pokérus.

Pokérus is no longer present in Scarlet & Violet! No assets for the Pokérus status icons exist in the game, and it can not be found on wild Pokémon.

After testing with a Pokémon forcibly given Pokérus, they still gain the usual EV yield (not x2), and Pokérus does not spread. pic.twitter.com/DIklfjbQHS

— Matt (@mattyoukhana_) November 18, 2022

While a virus surely sounds bad, Pokérus is actually completely beneficial. The status, which was indicated by a small icon, doubled the EV points that the infected Pokémon gained from battle, making training exceedingly easy.

All you had to do was place your Pokémon all around the infected and poof! Within hours, all your Pokémon would have the status.

With Scarlet and Violet, Pokérus is no more. The icon indicating the infections is gone, and there aren't any assets for it in the game. In fact, the status can't even be found on wild Pokémon.

So, for those of you trying to gain EV quickly and easily, hoping to get Pokérus isn't gonna be a great strategy.

Pokémon Scarlet and Violet have been to a rough start, with many players experiencing gameplay issues on the Nintendo Switch. According to IGN’s Rebekah Valentine in her review in progress: there really isn’t a moment in [Pokémon Scarlet & Violet] where’d I’d say they run well. Frame rates are dropping, Pokémon are clipping through walls and character models are popping in and out.

For our full review of Pokémon Scarlet and Violet, stay tuned to everything IGN.

Carson Burton is a freelance news writer for IGN. You can follow him on Twitter at @carsonsburton.

It's seemingly official: Pokérus is gone. Pokémon Scarlet and Violet just released on Thursday, but players are already discovering the rare, fictional disease is not present in the new games.

Pokérus was first introduced in Gen 2 Pokémon games. The status is essentially a virus; it infects any Pokémon adjacent to an infected Pokémon in your party, even though they're both still in Poké Balls.

The disappearance of Pokérus was discovered by Twitter user and dataminer @mattyoukhana_, who found that the game's code showed no indication of Pokérus.

Pokérus is no longer present in Scarlet & Violet! No assets for the Pokérus status icons exist in the game, and it can not be found on wild Pokémon.

After testing with a Pokémon forcibly given Pokérus, they still gain the usual EV yield (not x2), and Pokérus does not spread. pic.twitter.com/DIklfjbQHS

— Matt (@mattyoukhana_) November 18, 2022

While a virus surely sounds bad, Pokérus is actually completely beneficial. The status, which was indicated by a small icon, doubled the EV points that the infected Pokémon gained from battle, making training exceedingly easy.

All you had to do was place your Pokémon all around the infected and poof! Within hours, all your Pokémon would have the status.

With Scarlet and Violet, Pokérus is no more. The icon indicating the infections is gone, and there aren't any assets for it in the game. In fact, the status can't even be found on wild Pokémon.

So, for those of you trying to gain EV quickly and easily, hoping to get Pokérus isn't gonna be a great strategy.

Pokémon Scarlet and Violet have been to a rough start, with many players experiencing gameplay issues on the Nintendo Switch. According to IGN’s Rebekah Valentine in her review in progress: there really isn’t a moment in [Pokémon Scarlet & Violet] where’d I’d say they run well. Frame rates are dropping, Pokémon are clipping through walls and character models are popping in and out.

For our full review of Pokémon Scarlet and Violet, stay tuned to everything IGN.

Carson Burton is a freelance news writer for IGN. You can follow him on Twitter at @carsonsburton.